Constellation Brands remains a Buy, with valuation reflecting a solid margin of safety amid persistent macro headwinds and resilient brand performance. STZ reported strong Q1 FY27 results, beating estimates, growing beer business market share, and generating $485M in free cash flow, supporting buybacks and dividends. Guidance for FY27 is largely unchanged, projecting $1.6–$1.7B in free cash flow on ~$800M CAPEX, despite elevated marketing spend and ongoing consumer uncertainty.
STZ's premium brands, innovation and productivity initiatives position it for growth as consumers shift toward premium beverages.
Constellation Brands is upgraded to 'Strong Buy' due to compelling value, robust fundamentals, and market overreaction to Berkshire Hathaway's exit. STZ's beer segment, led by Modelo and Corona, drives 94% of sales and continues to gain U.S. market share with a robust 39% operating margin. STZ has medium-term growth potential via Modelo distribution, Cheladas, and non-alcoholic beer expansion.
Constellation Brands (STZ) reported earnings 30 days ago. What's next for the stock?
Constellation Brands NYSE: STZ held its 2026 annual meeting of stockholders on July 22, with shareholders approving all items presented for a vote, according to preliminary results announced during the meeting.
STZ's premium portfolio and beer leadership continue to fuel growth as it doubles down on innovation and premiumization.
Constellation Brands TodaySTZConstellation Brands$129.89 -0.45 (-0.35%) As of 11:35 AM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$126.45▼$178.13Dividend Yield3.17%P/E Ratio12.38Price Target$167.89Add to WatchlistConstellation Brands NYSE: STZ delivered its fiscal year 2027 Q1 report on June 30 with mixed results.
Constellation Brands is balancing strong beer demand and cash generation against wine and spirits weakness, margin pressure and a cautious fiscal 2027 outlook.
Constellation Brands trades at a discounted valuation, but beer strength must outweigh wine and spirits weakness and a cautious fiscal 2027 outlook.
STZ's beer business remains the key growth driver, offsetting weakness in Wine and Spirits and a cautious fiscal 2027 outlook.
Constellation Brands' Q1 results beat estimates as Beer growth, Wine and Spirits momentum, margin gains and cash flow offset softer beer depletions.
STZ tops Q1 earnings and sales estimates as beer strength, pricing gains and improved profitability help offset lower sales.